BMP 2 usage in posterior lumbar fusion in degenerative conditions

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Seminars in Spine Surgery

• Publication date

  2016-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1053/J.SEMSS.2016.08.007
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Exploratory meta-analysis on dose-related efficacy and morbidity of bone morphogenetic protein in spinal arthrodesis surgery.

  2016cited by this paper
• Adverse Events With the Use of rhBMP-2 in Thoracolumbar and Lumbar Spine Fusions: A 9-Year Institutional Analysis

  2015cited by this paper
• Lumbar pseudarthrosis: a review of current diagnosis and treatment.

  2015cited by this paper
• Cancer risk from bone morphogenetic protein exposure in spinal arthrodesis.

  2014cited by this paper
• Complications of Spinal Fusion With Utilization of Bone Morphogenetic Protein: A Systematic Review of the Literature

  2014cited by this paper
• Complications with the use of bone morphogenetic protein 2 (BMP-2) in spine surgery.

  2014cited by this paper
• Basic science and spine literature document bone morphogenetic protein increases cancer risk

  2014cited by this paper
• Does Recombinant Human Bone Morphogenetic Protein-2 Use in Adult Spinal Deformity Increase Complications and Are Complications Associated With Location of rhBMP-2 Use? A Prospective, Multicenter Study of 279 Consecutive Patients

  2014cited by this paper
• Cancer risk after use of recombinant bone morphogenetic protein-2 for spinal arthrodesis.

  2013cited by this paper
• Complications due to the use of BMP/INFUSE in spine surgery: The evidence continues to mount

  2013cited by this paper
• Recombinant human Bone Morphogenetic Protein-2 (rhBMP-2) in posterolateral lumbar spine fusion: complications in the elderly

  2013cited by this paper
• Transforaminal Lumbar Interbody Fusion With rhBMP-2 in Spinal Deformity, Spondylolisthesis, and Degenerative Disease—Part 2: BMP Dosage–Related Complications and Long-term Outcomes in 509 Patients

  2013cited by this paper
• High-dose rhBMP-2 for adults: major and minor complications: a study of 502 spine cases.

  2013cited by this paper
• Transforaminal Lumbar Interbody Fusion With rhBMP-2 in Spinal Deformity, Spondylolisthesis, and Degenerative Disease–Part 1: Large Series Diagnosis Related Outcomes and Complications With 2- to 9-Year Follow-up

  2013cited by this paper
• Safety and Effectiveness of Recombinant Human Bone Morphogenetic Protein-2 for Spinal Fusion

  2013cited by this paper
• Complications Associated With the Use of the Recombinant Human Bone Morphogenetic Proteins for Posterior Interbody Fusions of the Lumbar Spine

  2013cited by this paper
• The effect of recombinant human bone morphogenetic protein-2 in single-level posterior lumbar interbody arthrodesis.

  2013cited by this paper
• Clinical sequelae after rhBMP-2 use in a minimally invasive transforaminal lumbar interbody fusion.

  2012cited by this paper
• Adjuncts in posterior lumbar spine fusion: comparison of complications and efficacy

  2012cited by this paper
• RhBMP-2 use in lumbar fusion surgery is associated with transient immediate post-operative leg pain

  2012cited by this paper
• Osteolysis following resorbable poly-l-lactide-co-d, l-lactide PLIF cage use: a review of cases

  2012cited by this paper
• Perioperative complications with rhBMP-2 in transforaminal lumbar interbody fusion

  2011cited by this paper
• Complications With Recombinant Human Bone Morphogenic Protein-2 in Posterolateral Spine Fusion: A Consecutive Series of 1037 Cases

  2011cited by this paper
• Does Bone Morphogenetic Protein Increasethe Incidence of Perioperative Complicationsin Spinal Fusion?: A Comparison of 55,862 Cases of Spinal Fusion With and Without Bone Morphogenetic Protein

  2011cited by this paper
• A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: emerging safety concerns and lessons learned.

  2011cited by this paper
• Osteolysis in Transforaminal Lumbar Interbody Fusion with Bone Morphogenetic Protein-2

  2011cited by this paper
• Off-Label Use of Bone Morphogenetic Proteins in the United States Using Administrative Data

  2010cited by this paper
• Histopathologic inflammatory response induced by recombinant bone morphogenetic protein-2 causing radiculopathy after transforaminal lumbar interbody fusion.

  2010cited by this paper
• Complications Related to Osteobiologics Use in Spine Surgery: A Systematic Review

  2010cited by this paper
• Formation of Painful Seroma and Edema After the Use of Recombinant Human Bone Morphogenetic Protein‐2 in Posterolateral Lumbar Spine Fusions

  2010cited by this paper
• Symptomatic ectopic bone formation after off-label use of recombinant human bone morphogenetic protein-2 in transforaminal lumbar interbody fusion.

  2010cited by this paper
• Clinical and radiographic outcomes of posterolateral lumbar spine fusion in humans using recombinant human bone morphogenetic protein-2: an average five-year follow-up study

  2009cited by this paper
• Recombinant human bone morphogenetic protein-2 on an absorbable collagen sponge with an osteoconductive bulking agent in posterolateral arthrodesis with instrumentation. A prospective randomized trial.

  2009cited by this paper
• Complications associated with single-level transforaminal lumbar interbody fusion.

  2009cited by this paper
• The use of RhBMP-2 in single-level transforaminal lumbar interbody fusion: a clinical and radiographic analysis

  2009cited by this paper
• Recombinant Human Bone Morphogenetic Protein-2-Induced Radiculitis in Elective Minimally Invasive Transforaminal Lumbar Interbody Fusions: A Series Review

  2009cited by this paper
• Clinical and radiographic analysis of an optimized rhBMP-2 formulation as an autograft replacement in posterolateral lumbar spine arthrodesis.

  2009cited by this paper
• Adjacent vertebral body osteolysis with bone morphogenetic protein use in transforaminal lumbar interbody fusion.

  2008cited by this paper
• RhBMP-2 Versus Iliac Crest Bone Graft for Lumbar Spine Fusion: A Randomized, Controlled Trial in Patients Over Sixty Years of Age

  2008cited by this paper
• Complications in the Use of rhBMP-2 in PEEK Cages for Interbody Spinal Fusions

  2008cited by this paper
• Posterior lumbar interbody fusion using rhBMP-2

  2008cited by this paper
• Neurologic impairment from ectopic bone in the lumbar canal: a potential complication of off-label PLIF/TLIF use of bone morphogenetic protein-2 (BMP-2).

  2008cited by this paper
• Clinical and radiographic comparison of mini-open transforaminal lumbar interbody fusion with open transforaminal lumbar interbody fusion in 42 patients with long-term follow-up.

  2008cited by this paper
• Heterotopic Bone Formation With the Use of rhBMP2 in Posterior Minimal Access Interbody Fusion: A CT Analysis

  2007cited by this paper
• Interbody fusion with allograft and rhBMP-2 leads to consistent fusion but early subsidence.

  2007cited by this paper
• The Efficacy of rhBMP-2 for Posterolateral Lumbar Fusion in Smokers

  2007cited by this paper
• Vertebral Bone Resorption After Transforaminal Lumbar Interbody Fusion With Bone Morphogenetic Protein (rhBMP-2)

  2006cited by this paper
• Influence of rhBMP-2 on the Healing Patterns Associated With Allograft Interbody Constructs in Comparison With Autograft

  2006cited by this paper
• Clinical Outcomes and Fusion Success at 2 Years of Single-Level Instrumented Posterolateral Fusions With Recombinant Human Bone Morphogenetic Protein-2/Compression Resistant Matrix Versus Iliac Crest Bone Graft

  2006cited by this paper
• Posterior lumbar interbody fusion using recombinant human bone morphogenetic protein type 2 with cylindrical interbody cages.

  2004cited by this paper
• Degenerative Lumbar Spondylolisthesis With Spinal Stenosis: A Prospective Long-Term Study Comparing Fusion and Pseudarthrosis

  2004cited by this paper
• Use of Recombinant Human Bone Morphogenetic Protein-2 to Achieve Posterolateral Lumbar Spine Fusion in Humans: A Prospective, Randomized Clinical Pilot Trial 2002 Volvo Award in Clinical Studies

  2002cited by this paper
• Clinical and Radiographic Outcomes of Anterior Lumbar Interbody Fusion Using Recombinant Human Bone Morphogenetic Protein-2

  2002cited by this paper
• Anterior Lumbar Interbody Fusion Using rhBMP-2 With Tapered Interbody Cages

  2002cited by this paper
• Safety Profile for the Clinical Use of Bone Morphogenetic Proteins in the Spine

  2002cited by this paper
• Bone morphogenetic protein 2 exerts diverse effects on cell growth in vitro and is expressed in human pancreatic cancer in vivo.

  1999cited by this paper
• Bone morphogenetic protein and bone morphogenetic protein gene family in bone formation and repair.

  1998cited by this paper
• Antiproliferatiye effects of recombinant human bone morphogenetic protein‐2 on human tumor colony‐forming units

  1998cited by this paper
• Measurement of total and local bone morphogenetic protein concentration in bone tumours

  1997cited by this paper
• Pseudarthrosis of the Lumbar Spine

  1997cited by this paper
• Immunohistochemical detection of bone morphogenetic proteins in bone and soft‐tissue sarcomas

  1994cited by this paper
• Patient outcomes after lumbar spinal fusions.

  1992cited by this paper
• Novel regulators of bone formation: molecular clones and activities.

  1988cited by this paper
• The rate of pseudarthrosis (surgical nonunion) in patients who are smokers and patients who are nonsmokers: a comparison study.

  1986cited by this paper

• Combining Expandable Interbody Cage Technology With a Minimally Invasive Technique to Harvest Iliac Crest Autograft Bone to Optimize Fusion Outcomes in Minimally Invasive Transforaminal Lumbar Interbody Fusion Surgery

  2021cites this paper
• Polymer scaffolds as drug delivery systems

  2020cites this paper